Aim Despite advances in the management of liver diseases and changes etiology cirrhosis, few studies have updated prognosis cirrhosis. This study aimed to clarify recent cirrhosis identify risk factors for death. Methods In this retrospective observational by Hepatic Disease Network National Hospital Organization Japan, chart reviews were performed follow patients with beginning 2011. We conduc...

Abstract Background Hepatic encephalopathy exacerbates the morbidity, delays hospital discharge, and increases rate of readmissions cirrhotic patients, particularly those are admitted by acute variceal bleeding. We evaluated performance albumin-bilirubin score in prediction hepatic patients with bleeding, comparison to Child-Pugh MELD scores. This prospective cohort study was conducted on 250 w...

BACKGROUND AND AIM Several models have been developed to predict survival in patients with cirrhosis undergoing TIPS; however, few of these models have gained widespread acceptance, especially in the era of covered stents. The aim of this study was to establish an evidence-based model for predicting survival after TIPS procedures. METHODS A total of 210 patients with cirrhosis treated with TI...

Background: Alteration of cardiovascular functions in patients with liver cirrhosis has been described and it correlates with severity of hepatic failure. But cardiac function by conventional echocardiography has limitations and cardiac decompensation occurs when the heart is challenged. Aim: To evaluate cardiac systolic and diastolic functions in patients with liver cirrhosis by conventional D...

AIM: To evaluate and compare the clinical usefulness of C-phenylalanine and C-methacetin breath tests in quantitating functional hepatic mass in patients with chronic liver disease and to further compare these results with those of conventional tests, Child-Pugh score and serum

AIM To study sleep aspects and parameters in cirrhotic patients and assess the role of liver dysfunction severity in polysomnographic results. METHODS This was a case-control study. Patients with a diagnosis of liver cirrhosis were consecutively enrolled in the study. Clinical examinations and laboratory liver tests were performed in all patients, and disease severity was assessed using the C...

Sorafenib is an oral multi-kinase inhibitor that increases survival and delays tumor progression in patients with advanced hepatocarcinoma (HCC). This study aimed to determine the progression-free (PFS) overall (OS) analyze OS-related factors this population between 2014 2019. We performed a retrospective review of HCC who were treated sorafenib at National Cancer Institute Panama (Instituto On...

BACKGROUND Portal hypertension in patients with liver cirrhosis causes manifestations such as esophageal varices, ascites and edema. Some studies have been conducted about the role of esophageal varices in the development of esophageal motor disorders and abnormal gastroesophageal reflux in these patients. Ascites could be a factor promoting gastroesophageal reflux and it has been questioned wh...